Web-delivered Provider Intervention for Tobacco Control (QUIT-PRIMO)
|ClinicalTrials.gov Identifier: NCT00797628|
Recruitment Status : Completed
First Posted : November 25, 2008
Last Update Posted : August 28, 2013
|Condition or disease||Intervention/treatment|
|Smoking Cessation||Behavioral: Decide2Quit Behavioral: Smoking Coach|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||174 participants|
|Intervention Model:||Factorial Assignment|
|Masking:||Double (Participant, Investigator)|
|Primary Purpose:||Health Services Research|
|Official Title:||QUIT-PRIMO: Web-Delivered Clinical Microsystem Intervention for Tobacco Control|
|Study Start Date :||March 2010|
|Primary Completion Date :||August 2013|
|Study Completion Date :||August 2013|
Experimental: Information Prescription
Providers will give usual care to patients who smoke and a paper prescription with the name and url of the "Smoking Coach" website. The smoking coach website is a tailored, public health intervention for smoking cessation.
Behavioral: Smoking Coach
Control Patients will be referred by paper prescription to the control- "Smoking Coach" website.
Providers will give usual care to patients who smoke and then refer patients to the online smoking cessation system electronically.
Patient intervention website that includes 1) interactive calculators to assess readiness to quit, symptoms and quit plan, 2) motivational content, and 3) links to other high quality information.
- Physician performance on refering patients that smoke cigarettes to the web intervention [ Time Frame: pre-intervention, 6 months, 12 months and 24 months ]
- Of the smokers who are referred to the web intervention, the number who go to the site [ Time Frame: preintervention, 6 months, 12 months, 24 months ]
- Point prevalence smoking cessation [ Time Frame: 6 months ]
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00797628
|United States, Massachusetts|
|University of Massachusetts Medical School|
|Worcester, Massachusetts, United States, 01655|
|Principal Investigator:||Thomas K Houston, MD||University of Massachusetts, Worcester|